The company said it intends to reaffirm its FY2025 diluted earnings per common share (EPS) guidance of approximately $14.68 with investors and analysts at meetings on December 31, 2025.

1. 01

   The company said it intends to reaffirm its FY2025 diluted earnings per common share (EPS) guidance of approximately $14.68 with investors and analysts at meetings on December 31, 2025.

2. 02

   The company said it will reaffirm its FY2025 adjusted earnings per common share (Adjusted EPS) guidance of approximately $16.25, which is consistent with the outlook in its press release dated April 30, 2025.

3. 03

   Humana said its FY2025 guidance bridges GAAP diluted EPS of approximately $14.68 to Adjusted EPS of approximately $16.25, after adjusting for amortization of identifiable intangibles of 0.49, put/call valuation adjustments on non-consolidating minority interest investments of 1.35, value creation initiatives of 0.20, and a cumulative net tax impact of (0.47).

4. 04

   The company said its senior management will meet with investors and analysts at various meetings between June 2, 2025 and June 30. It said it will also host an Investor Conference on Monday, June 16, 2025, beginning at 2 p.m. EST, and live-stream it.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.